Lupus diagnosis relies on a combination of blood tests rather than a single definitive one. The most important starting point is the antinuclear antibody (ANA) test, which is positive in about 98% of people with systemic lupus. From there, doctors use a panel of more specific antibody tests, blood counts, and inflammation markers to confirm the diagnosis and track disease activity over time.
The ANA Test: First Step in Screening
The ANA test detects antibodies that mistakenly target your own cell nuclei. It’s the most sensitive screening tool for lupus, catching 98% of cases. Under the current classification system used by rheumatologists, a positive ANA at a titer of 1:80 or higher is actually the entry requirement before other lupus criteria are even considered.
Results come back as a titer, which reflects how many times your blood sample was diluted before antibodies were no longer detectable. A titer of 1:640 means antibodies were still present after more dilutions than a titer of 1:320, indicating a higher concentration. Higher titers are more clinically significant, but the number alone doesn’t confirm lupus.
That’s the key limitation of the ANA test: it’s very good at ruling lupus out, but a positive result doesn’t rule it in. Plenty of healthy people test positive for ANA, especially at lower titers. So do people with other autoimmune conditions, certain infections, and even some medications. A positive ANA simply opens the door to more specific testing. ANA-negative lupus does exist but is very rare, and sometimes results from lab variability rather than a true absence of these antibodies.
Antibody Tests That Point Specifically to Lupus
Once the ANA comes back positive, the next round of blood work looks for antibodies that are far more specific to lupus. Two matter most:
- Anti-double-stranded DNA (anti-dsDNA): These antibodies target your own DNA and are strongly linked to lupus, particularly kidney involvement. Levels often rise during disease flares and drop when things are under control, making this test useful for both diagnosis and ongoing monitoring.
- Anti-Smith (anti-Sm): These antibodies are highly specific to lupus. When present, they’re a strong indicator. However, only a subset of lupus patients have them, so a negative result doesn’t rule the disease out.
Your doctor may also check for other autoantibodies like anti-Ro (SSA) and anti-La (SSB), which are associated with specific lupus features such as skin rashes and neonatal lupus risk during pregnancy. Together, these antibody results form one piece of a scoring system. Under the 2019 classification criteria, clinical and immunological findings are assigned different point values, and a total of 10 or more points qualifies as lupus classification.
Complete Blood Count
A complete blood count (CBC) is one of the most basic blood tests, but it reveals a lot in lupus. The disease can suppress your bone marrow or cause your immune system to destroy blood cells, leading to drops across multiple cell lines.
About 40% of people with lupus develop anemia at some point during their disease. This can cause fatigue, shortness of breath, and pale skin. Lupus can also lower your white blood cell count (leukopenia), leaving you more vulnerable to infections, or reduce your platelet count (thrombocytopenia), which increases bruising and bleeding risk. Because these changes can fluctuate with disease activity, a CBC is part of nearly every lupus-related blood draw.
Complement Levels: Tracking Inflammation
Your complement system is a set of proteins that help your immune system clear out foreign invaders and damaged cells. In lupus, the immune system is overactive, which uses up complement proteins faster than your body can replace them. The two most commonly measured are C3 and C4.
Low C3 and C4 levels suggest your body is actively attacking its own tissues, which often correlates with a lupus flare. When complement levels rise back toward normal during treatment, it’s a sign that the inflammation is coming under control. These tests are especially useful for monitoring kidney involvement, where complement-driven damage can be serious.
Antiphospholipid Antibodies and Clotting Risk
Roughly one-third of lupus patients carry antiphospholipid antibodies, which increase the risk of dangerous blood clots in veins or arteries. This is tested through a few different measures: the lupus anticoagulant test and anticardiolipin antibody test are two of the earliest recognized markers. A false-positive syphilis test was historically the third clue, since the same antibodies interfere with the reagents used in syphilis screening.
If you test positive for these antibodies, your doctor will assess your clotting risk more carefully. This matters for treatment decisions, especially if you’re planning a pregnancy, since antiphospholipid antibodies also increase the risk of miscarriage and pregnancy complications.
Kidney and Liver Function Tests
Lupus can quietly damage the kidneys long before you notice symptoms. Blood tests measuring creatinine and blood urea nitrogen (BUN) assess how well your kidneys are filtering waste. These are typically paired with a urinalysis to check for protein or blood in your urine, both early signs of lupus nephritis.
Liver enzymes are also checked routinely, both to screen for lupus-related liver inflammation and because many lupus medications can affect liver function over time.
Inflammation Markers
Two general inflammation tests often appear on lupus blood panels. The erythrocyte sedimentation rate (ESR) and C-reactive protein (CRP) both measure how much inflammation is present in your body. Neither is specific to lupus, but they help your doctor gauge overall disease activity and distinguish a lupus flare from other causes of your symptoms.
How Often These Tests Are Repeated
Lupus blood work isn’t a one-time event. If your disease is mild and stable, you can expect routine blood tests every three to six months. During active flares or when starting new treatment, that frequency increases to every one to three months. A typical monitoring visit includes anti-dsDNA antibodies, complement levels, CRP, a CBC, kidney and liver function tests, and urinalysis.
This regular testing serves two purposes: catching organ damage early (especially in the kidneys) and detecting flares before they become severe. Changes in complement levels or a rising anti-dsDNA titer can signal worsening disease even before you feel different, giving your care team a chance to adjust treatment proactively.